GHC

In the past six months (April-October 2026), GHC stock experienced fluctuations, with the share price at $1,143.43 as of September 18, 2026, representing a 1.55% decline from September 22, 2025. More recently, the stock increased by 1.46% weekly and 5.53% monthly, with annual increases of 8.07% and 15.53%. Key events included the Q1 2026 earnings report on April 30, 2026, and the Q2 2026 earnings report on July 30, 2026, where the company reported earnings of $64.86 per share, significantly exceeding estimates. Revenue for the first half of 2026 climbed from $1.22 billion to $1.30 billion, with profitability expanding from $36.7 million to $281.1 million. The sale of KLG in Q1 2026 negatively impacted education segment revenue. The healthcare segment saw revenue surge from $202.2 million to $247.7 million in Q2 2026 due to expanded offerings and the purchase of Pine Drug Holdings, while television broadcasting revenue grew from $106 million to $109.6 million. A regular quarterly dividend of $1.88 per share was declared, payable on November 5, 2026, and the next earnings report is scheduled for November 4, 2026.